Tags

Type your tag names separated by a space and hit enter

Überantibodies From Recovered COVID-19 Patients Could Spur New Therapeutics and Vaccines.
JAMA. 2021 Aug 17; 326(7):589-590.JAMA

Authors

No affiliation info available

Pub Type(s)

News

Language

eng

PubMed ID

34319350

Citation

Abbasi, Jennifer. "Überantibodies From Recovered COVID-19 Patients Could Spur New Therapeutics and Vaccines." JAMA, vol. 326, no. 7, 2021, pp. 589-590.
Abbasi J. Überantibodies From Recovered COVID-19 Patients Could Spur New Therapeutics and Vaccines. JAMA. 2021;326(7):589-590.
Abbasi, J. (2021). Überantibodies From Recovered COVID-19 Patients Could Spur New Therapeutics and Vaccines. JAMA, 326(7), 589-590. https://doi.org/10.1001/jama.2021.12915
Abbasi J. Überantibodies From Recovered COVID-19 Patients Could Spur New Therapeutics and Vaccines. JAMA. 2021 Aug 17;326(7):589-590. PubMed PMID: 34319350.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Überantibodies From Recovered COVID-19 Patients Could Spur New Therapeutics and Vaccines. A1 - Abbasi,Jennifer, PY - 2021/7/29/pubmed PY - 2021/8/24/medline PY - 2021/7/28/entrez SP - 589 EP - 590 JF - JAMA JO - JAMA VL - 326 IS - 7 SN - 1538-3598 UR - https://www.unboundmedicine.com/medline/citation/34319350/Überantibodies_From_Recovered_COVID_19_Patients_Could_Spur_New_Therapeutics_and_Vaccines_ L2 - https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.12915 DB - PRIME DP - Unbound Medicine ER -